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                                                       ABSTRACT 
TITLE OF THE ABSTRACT: Intrathecal morphine or clonidine for postoperative 
analgesia in patients undergoing urethroplasty- a comparison. 
BACKGROUND: 
Urethroplasty, a surgical repair is attempted as corrective measure in the male urethra for 
urethral stricture after conservative and non-surgical methods does not produce the 
desired patient satisfaction. The perineal region is an area supplied with a profuse sensory 
nervous supply. Surgical procedures to the region may produce severe pain in the post-
operative period. 
OBJECTIVES:                                                                                                                                                         
To compare the effectiveness of intrathecal morphine and clonidine for postoperative 
analgesia and their effect on postoperative sedation, nausea and vomiting and time to 
mobilization in patients undergoing urethroplasty surgery.  
METHODS: 
Type of study: Prospective Randomized Controlled double blinded study.  
After approval by the institutional review board, total of 46, ASA grade I and II patients 
were enrolled and randomly assigned to two groups after informed consent over a period 
of six months. Group A (23 patients) received morphine (3mcg/kg body wt.) and Group 
B (21 patients) received clonidine (1mcg/kg body wt.) intrathecal injection prior to 
 
 
general anaesthesia. Heart rate, systolic, diastolic and mean blood pressures were 
monitored at regular intervals. During the post- operative period VAS score, Ramsay 
sedation score, PONV were assessed at 0,1,2,4,8,12 and 24hrs. 
RESULTS: 
Intrathecal clonidine (1 gm/kg body weight) provides effective hemodynamic stability 
during laryngoscopy than intrathecal morphine (3µgm/kg body weight).The average 
duration of surgery(median 4hrs),  the analgesic effect of clonidine is comparable to the 
analgesic effect of morphine in the early postoperative period, i.e., first 12hrs post 
surgery and morphine has prolonged analgesic effect. Though statistically insignificant (p 
value >0.05) clonidine has prolonged analgesic effect on buccal mucosa than morphine. 
There is no significant sedative effect and PONV in both groups. 
CONCLUSION: 
Clonidine had significantly better intraoperative hemodynamic response to sympathetic 
response to painful stimulation during intubation and skin incision. Morphine provided a 
moderately longer duration of pain relief compared to clonidine. The prolonged analgesic 
effect on buccal mucosa could possible because of the central alpha 2 agonist activity of 
clonidine. 
KEY WORDS: 
Intrathecal clonidine, intrathecal morphine, urethroplasty, post-operative pain, sedation, 
PONV, buccal pain 
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                                                        INTRODUCTION                                                                                                                               
Male urethral stricture is prevalent disease and has a substantial impact on quality of life 
and health(1). Treatment of urethral strictures is complex and depends on the 
characteristics of the stricture. Urethral strictures are managed initially by urethral 
dilation and internal urethrotomy. Studies have shown that long-term success rates are 
higher for surgical reconstruction with urethroplasty, with success rates of 85–
90%(1).The nerve supply of prostate, prostatic urethra, penis and scrotum is primarily 
lumbosacral. Spinal levels of pain conduction are -prostrate, penis (S2-S4), scrotum (S2-
S4), testes (T10-L1). Injection of local anaesthetic drug into the subarachnoid space at 
L2-L3 or L3-L4 intervertebral space results in motor and sensory blockade. The principal 
sites of action of local anaesthetic are the nerve roots within the intrathecal space. 
Addition of morphine or clonidine improves both the quality and duration of analgesia. 
Since 1979,Morphine is used as an adjunct to spinal anaesthesia for postoperative 
pain(2).Morphine primarily acts on mu and kappa opioid receptors . Activation of opioid 
receptors results in inhibition of the presynaptic release and postsynaptic response to 
excitatory neurotransmitters (e.g. acetylcholine, substance P) from nociceptive neurons. 
Clinical effects of intrathecal morphine are spinal analgesia (kappa receptor) and 
supraspinal analgesia (mu1 receptor). Unwanted side effects are respiratory depression, 
muscle rigidity, and sedation but with doses less that 300mcg these side-effects were 
minimal(3). Intrathecal morphine, in low doses, in combination with spinal anaesthesia 
has been safety used in caesarean sections, TURP, gynaecological and orthopaedic 
surgeries. 
2 
 
Clonidine is an alpha-2 agonist. Clonidine exerts its action on the sensory nerves in the 
spinal cord by depressing C-fibre neurotransmitters and hyperpolarization of post 
synaptic dorsal horn neurons. Clonidine’s ability to prolong motor paralysis is due to its 
affinity for alpha-2 postsynaptic receptors within the dorsal horn. Clonidine has been 
used in a varying doses ranging from 30 to 300 mcg intrathecally. When given with local 
anaesthetics the maximum dose used is between 1-2 mcg/kg. Higher does are found to 
cause  unwanted effects such as bradycardia, hypotension, and marked sedation(4). 
Plateau effect of clonidine is seen around 150 mcg(5). The addition of clonidine has been 
found to decrease postoperative pain in patients who undergo transurethral resection of 
prostate(TURP)(6). There has been no known publication on its use in urethroplasty. 
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                                    AIMS AND OBJECTIVES 
Aims: 
The aim of the study is to evaluate the effect of intrathecal clonidine versus intrathecal 
morphine in postoperative pain relief among patients undergoing urethroplasty 
Objectives: 
1) To compare the effectiveness of intrathecal morphine and intrathecal clonidine to 
provide postoperative analgesia in patients undergoing urethroplasty surgery. 
2) To compare the effect of intrathecal morphine and intrathecal clonidine on 
postoperative sedation, postoperative nausea and vomiting and time to mobilization. 
Hypothesis: 
Intrathecal clonidine is as effective as intrathecal morphine in treating postoperative pain 
in patients undergoing urethroplasty surgery with less unwanted effects of morphine. 
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                                   REVIEW OF LITERATURE 
PAIN: 
An unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage.(7) 
MECHANISM OF PAIN: 
Pain has been classified as acute pain which is  physiological and does not last for more 
than 3 to 6 months duration  and chronic pain ,that is pathological which is  lasting for 
more than 3-6 months, or persisting beyond the time for tissue healing.(8) It can be 
produced due to mechanical, chemical, or thermal stimuli.  Pain sensation has an afferent 
and efferent pathway. Pain sensation arises from the unmyelinated dendrites of sensory 
neurons located around the hair follicles and in deep tissues. Nociceptor impulses are 
transmitted via A  fibers (myelinated) and C fibres (unmyelinated). The noxious stimuli 
produce electrophysiological activity in nociceptive primary afferent nerve fibres due to 
the release of mediators released by damaged cells. This results in transport of chemicals 
such as neurotrophins along axons to the cell bodies of the dorsal root ganglia, which 
results in alteration of the chemistry and physiology of the sensory cell. Modulation of 
sensory impulses occurs both at the dorsal horn of the spinal cord and also by descending 
control systems originating in the cortex, thalamus and brainstem. Transmission of 
sensory impulses occurs to various parts of the central nervous system which results in 
registration and localization and production of affective responses. Brain doesn’t have a 
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discrete pain centre. The responses to pain are produced through integrated activity of 
various areas of the brain. 
The somatosensory pathways involved in the transmission of pain are spinothalamic tract 
and spinoreticular pathway. The fibres from the nociceptors synapse on neurons in the 
dorsal horn. The axon of these neurons cross the mid line and forms the spinothalamic 
tract which synapses in the VPL nuclei. The painful input received by the other dorsal 
horn neurons synapses in the reticular formation of the brain stem and forms 
spinoreticular pathway and then project to the contralateral thalamic nucleus. 
Pain processing includes four elements(9)- 
1) Transduction: It is a process of conversion of noxious stimuli into an action potential 
2) Transmission : It is conduction of  action potential through the nervous system via the 
first-, second-, and third-order neurons ,which have cell bodies located in the dorsal root 
ganglion, dorsal horn, and thalamus. 
3) Modulation: It involves either inhibition or augmentation of the pain signals and 
perception by altering afferent neural transmission along the pain pathway. 
4) Perception: It is the final common pathway, which is due to integration of painful input 
into the somatosensory and limbic cortices. Our traditional anaesthetic technique target or 
treat only this component of pain processing. 
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Schematic representation of acute pain pathway: 
 
 
                                                  
                   
                              
                                              
 
 
 
 
 
                                                   
                                         
            
 
    TISSUE INJURY 
Local release of active factors (prostaglandins, bradykinins, cytokines) 
Acute activation of sensory afferents (A𝛿 and C fibers) 
Generates input into the spinal cord 
Activation of neurons that 
project contralaterally to the 
thalamus and thence to the 
somatosensory cortex system. 
Spinal facilitation to the 
Medial thalamus, anterior 
cingulate cortex and limbic 
system. 
Exaggerated output for given stimulus input 
Acute pain + Hyperalgesia 
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 CLINICAL IMPLICATIONS OF PAIN: 
There are many systemic side effects due to poorly managed pain. The cardiovascular 
side effect consists of increase in heart rate, blood pressure and cardiac workload. 
Intraoperative blood loss will be more due to rise in blood pressure. The respiratory 
system is also affected. There may be splinting of the respiratory muscle due to pain 
which results in decrease in vital capacity and atelectasis. Poor respiratory effort in the 
postoperative period results in retained secretions in the alveoli which becomes a source 
of infection. There is an increased chance of urinary retention but this may not be a 
problem for urethroplasty patients as they all have indwelling urinary catheter. Pain 
prevents early postoperative mobilization which increases the risk for thromboembolism. 
Pain creates anxiety and fear which finally results in poor patient satisfaction. 
ASSESSMENT OF PAIN: 
Assessment of pain is essential for effective pain management. For assessment of pain 
intensity in the postoperative period, the well-known visual analogue scale (VAS) and 
numeric rating scale (NRS) are equally sensitive and they are both superior to a four-
point verbal categorical rating scale (VRS).(10) They are more useful for the assessment 
of the patient's subjective feeling of pain intensity. They may be used for pain assessment 
over the last 24 h, or during the last week. The numerical rating scale (NRS) consists of 
numbers from 0 to 10. 0 equates to no pain and a score of 10 is worst pain imaginable. 
Assessment of the intensity of pain when the patient is  mobile and taking deep breathing, 
and coughing is as important as assessing pain at rest after surgery because inadequate 
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dynamic pain relief increases risks of cardiopulmonary complications and 
thromboembolic phenomenon after surgery. Immobilization in the postoperative period 
may result in chronic hyperalgesic pain. 
MANAGEMENT OF ACUTE POST-OPERATIVE PAIN: 
As per ASA guidelines, the  management of perioperative pain should include appropriate 
dose adjustments of medications to  avoid  abstinence syndrome, to treat pre-existing pain 
and preoperative initiation of therapy for postoperative pain management.(11) Patient and 
family education is important in achieving comfort, reporting pain, and in proper use of 
the recommended analgesic methods. Administration of two or more drugs that act by 
different mechanisms, i.e., multimodal techniques is proven to be more effective in 
providing analgesia in the postoperative period. They can be given by any route of 
administration. The various modalities of pain management in postoperative 
urethroplasty patients are 
 Oral or intravenous acetaminophen ,Non-steroidal anti-inflammatory drugs 
(NSAIDs) and  Cyclooxygenase inhibitors(COX-2 inhibitors) 
 Opioids, i.e., oral or intravenous tramadol, subcutaneous morphine, PCA (patient 
controlled analgesia) morphine, Fentanyl or buprenorphine patch. 
 Central Neuraxial techniques include injection of drugs into the epidural and 
subarachnoid space. It may be either single injection of opioids or non-opioids 
drugs like clonidine ( 2 agonist) with or without local anaesthetics intrathecally 
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or in to the epidural space or continuous epidural infusion of local anaesthetics 
with or without adding opioids. 
Each of the above mentioned modalities have their own advantages and disadvantages. 
NSAIDs are inhibitors of cyclooxygenase which prevents formation of Prostaglandin E2 
from arachidonic acid. NSAIDs provide excellent analgesia but may contribute to 
postoperative nausea and vomiting. In addition they may also result in platelet 
dysfunction, which may worsen or precipitate haemorrhage. The concerns regarding 
COX-2 inhibitors are that they may cause adverse cardiovascular effects. 
Opioid analgesics are commonly used drugs for the treatment of postoperative pain. They 
exert their analgesic effects through μ receptors in the CNS by directly modulating the 
nociceptive process. They can be administered in different routes such as subcutaneous, 
intramuscular, intravenous or by central Neuraxial techniques. After major surgeries 
opioid analgesics are commonly given through Patient-controlled analgesia (PCA). A 
variety of narcotic medications like morphine, hydromorphone, meperidine, fentanyl can 
be self-administered using this  programmable delivery system (12). The incidence of 
opioid-related side effects resulting from using intravenous PCA  is similar to other 
routes of administration(13). The prolonged analgesic efficacy of opioids is limited by 
the development of tolerance. The other side effects of opioids are nausea, vomiting, 
sedation, respiratory depression through depression of brainstem control of respiratory 
drive, decrease in blood pressure which is common in hypovolemic patients and urinary 
retention. Morphine administration results in histamine release and may produce flushing, 
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tachycardia, hypotension, pruritus, and bronchospasm. Prolonged administration of 
morphine slows down gastrointestinal transit time and results in constipation and ileus in 
many patients. 
Continuous epidural infusion is one of the commonly practiced methods for pain 
management both intra-operatively and postoperatively in patients undergoing major 
abdominal and perianal surgeries. Either low concentration of local anaesthetics or 
combined with opioids are used as infusions. It provides good analgesia in majority of 
patients when infusion is given at appropriate dermatome level.(14) Correct placement of 
epidural catheter requires technical expertise. The most common reason for poor pain 
control in patients with epidural infusion is malposition or dislodgment of epidural 
catheter. Other serious but less common complications are profound hypotension, 
migration of the epidural catheter into intravenous or subarachnoid space, epidural 
abscess formation, and epidural hematoma which may result in serious neurological 
sequaelae. 
URETHRAL STRICTURE: 
Urethral stricture is narrowing of urethra caused due to inflammation or due to scar tissue 
after trauma like pelvic fractures, urinary catheterization, prostate surgeries or post 
radiation. It is more common in male population(15). It is almost always acquired 
condition and mostly iatrogenic. (16) 
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Common symptoms include  urinary retention, strong urge to urinate and frequent 
urination, painful or difficulty in urinating, slow urine stream, swelling of the penis, loss 
of bladder control, pain in the lower abdomen and pelvic region, blood in the semen, 
discharge from the urethra, bloody or dark urine 
ANATOMY OF MALE URETHRA: 
Normal male urethra is a fibro muscular tubular structure, 18-20 cms long. It starts at the 
internal urethral orifice in the trigon of the bladder and opens in the navicular fossa of the 
glans penis at the external urethral meatus, which is the narrowest part of the urethra. It is 
divided in to a posterior part and an anterior part. The posterior part, which extends from 
the bladder neck to the distal external urethral sphincter, can be divided into the prostatic 
and the membranous urethra. Membranous urethra is 1 cm long and it passes through the 
urogenital diaphragm, surrounded by sphincter urethrae. It is the shortest and narrowest 
portion of urethra. Prostatic urethra is 3 cm long and is surrounded by the prostate gland. 
On its posterior wall lies the smooth muscle verumontanum which receives the 
ejaculatory ducts.                                                                                                        
The anterior urethra extends from the distal external urethral sphincter to the external 
urinary meatus and is divided into the bulbar, penile and navicularis urethra(17). Penile 
or spongy urethra is16 cm long and is encased by corpus spongiosum of the penis. It is 
the longest portion of male urethra. Bulbar or bulbous urethra traverses the root of the 
penis and  it receives the ducts from the bulbourethral glands and  the glands of Littre .  
Patients with urethral strictures complains of  voiding symptoms like  slow stream, 
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intermittent stream, straining, hesitancy, increased daytime frequency, urgency, nocturia 
,acute urinary  recurrent urinary tract infection(18).Various surgical interventions for 
urethral stricture are  urethrotomy  (optical cold knife urethrotomy) ,  simple urethral 
dilatation and urethroplasty (anastomotic or substitution).The type of surgical 
intervention required depends on  length of the stricture: less than 2 cm versus more than 
2 cm, location of the stricture, bulbar versus penile, number of previous interventions: 
two or more versus less than two(19).There is an increased trend towards urethroplasty as 
primary intervention are  associated with recurrence and eventual urethroplasty(20). 
Nerve supply of male genitalia: 
Male genitalia are supplied by the pudendal nerve (S2-S4). The perineal branch of the 
pudendal nerve supplies the posterior part of the scrotum and the rectal nerve to the 
inferior rectal area.  Cutaneous innervation of penis and scrotum arises from the dorsal 
and posterior branch of the pudendal nerve. The ilioinguinal nerve supplies the anterior 
part of the scrotum and proximal penis after it exits the superficial inguinal canal. The 
ischiocavernous and bulbocavernous muscles are supplied by the pudendal nerve. The 
pudendal nerve branches into the inferior rectal nerve and the scrotal nerve and continues 
as the dorsal nerve of the penis. 
Autonomic nerves supply is from sympathetics that arise from lumbar segments L1 and 
L2 and parasympathetics from S2-4 (Nervi erigentes or pelvic nerve). Lumbar splanchnic 
nerves join the superior hypogastric plexus over the aortic bifurcation, left common vein 
and sacral promontory. From this plexus, right and left hypogastric nerves travel medial 
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to the internal iliac artery to the inferior hypogastric plexus. The pelvic plexus adjacent to 
the base of the bladder, prostate, seminal vesicles and rectum contain parasympathetic 
fibres as well. Nerves from the inferior pelvic plexus supply the prostate, seminal 
vesicles, epididymis, membranous and penile urethra and bulbourethral gland. 
The cavernous nerves arise from the pelvic plexus. They supply the corpus cavernosum 
and penile urethra, and terminate in a delicate network around the erectile tissue. 
URETHROPLASTY: 
Urethroplasty is the repair of an injury or defect within the walls of the urethra. 
Types of urethroplasty: 
The different types of urethroplasty surgeries are  anastomotic, buccal mucosal on lay 
graft, scrotal or penile island flap (graft), and Johansen's urethroplasty.(21) The choice of 
procedure depends on many factors like: 
 length of the defect 
 physical condition of the patient 
 availability of auto graft tissue(buccal mucosa or tissue from penis or scrotum) 
 multiple or single stricture 
Preoperative evaluation: 
This consists of identification of medical co-morbidities and optimization of the same. 
Investigations include routine blood investigations, urine analysis and urine culture and 
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investigations for the underlying comorbid illness and specifically for the urethral 
stricture assessment like Post void residual urine, Uroflometry, Micturiting Cysto-
urethrogram, Urethroscopy, Cystoscopy and ultrasonography of the abdomen and pelvis. 
Positioning for surgery: 
The frequently used position during urethroplasty is lithotomy with a trendelenburg tilt 
(head down tilt). Lithotomy position include – 80 to 100 degree of flexion at hips, 30 to 
40 degree abduction from the midline and flexion of knee such that the leg may lie 
parallel to the trunk. The legs are held up with the help of stirrups. The lower extremities 
are padded to prevent compression against the stirrups. For placing the patient in 
lithotomy position, coordinated positioning of the lower extremities of patient by two 
assistants is essential to avoid torsion of the lumbar spine. The foot section of the surgical 
table is lowered and head-down tilt (trendelenburg position) will be given. 
Pathophysiological changes during lithotomy and trendelenburg position(22): 
Cardiovascular effects: 
When the legs are elevated and head is lowered venous return increases and results in 
transient increase in cardiac output. This reduces perfusion gradients to the lower limbs 
and improves access to the perineal surgical site. 
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Respiratory effects: 
Lithotomy position results in cephalad displacement of diaphragm by the abdominal 
viscera resulting in reduction of lung compliance which subsequently results in decrease 
in tidal volume. Head down tilt results in increased venous return from lower extremities. 
This causes reflex vasodilation and congestion of poorly ventilated lung apices and 
results in ventilation and perfusion mismatch. 
Neurological effects: 
The common peroneal nerve is the most commonly involved nerve in  positioning related 
neuropathy It comprises 78% of nerve injuries in lithotomy position. 
Compartment syndrome:(23) 
In lithotomy position compression of calf muscles results in venous stasis and venous 
thromboembolism and compartment syndrome. It is more common in prolonged 
surgeries (surgeries >5hrs duration). 
Early clinical manifestations of compartment syndrome(24)  include pain in the affected 
extremity, oedema, pain on external pressure. Late clinical signs include absence of distal 
pulses, paraesthesia and paresis. Symptoms and signs are generally not reliable for the 
diagnosis. Postoperatively, difficulties with pain control might be the only sign. 
Differential diagnosis includes DVT, arterial injury and peripheral nerve damage. 
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Surgical technique: 
Anastomotic urethroplasty: 
 Patient positioned in lithotomy position and local preparation done. 
 Methylene blue is injected into the urethra. 
 The distal extent of the stenosis is identified by inserting a 16- French catheter 
with a soft round tip. 
 Midline perineal incision is made. 
 The urethra is freed from the bulbocavernous muscle. 
 The urethra is dissected from the corpora cavernosa. 
 The distal extent of the stenosis is identified and outlined. 
 The urethra is transected at the stricture level. 
 The stricture is resected  and  the urethra is spatuled for 1 cm on both ends. A total 
of 10 interrupted 4-zero polyglactin sutures are put in place before tying. 
 A Foley 16-French grooved silicone catheter is inserted and the urethra is closed 
and the anastomosis is completed on the roof. 
 Once the anastomosis is completed two ml of fibrin glue are injected over the 
urethra to prevent urinary leakage. 
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Substitution urethroplasty: 
 Two surgical teams work simultaneously. 
 The steps are similar to anastomotic urethroplasty till the dissection of urethra 
from the corpora cavernosa and identification and outlining the distal extent of  the 
stenosis. 
 The urethra is transected at the stricture level and the distal and proximal urethral 
ends are mobilized from the corpora cavernosa. 
 The distal and proximal urethral ends are fully spatuled along the dorsal surface. 
 Two ml of fibrin glue are injected over the urethra and the buccal mucosal graft is 
applied over the fibrin glue. 
 The distal and proximal urethral edges are sutured to the apices of the graft. The 
distal urethra is pulled down and the proximal urethra is pulled up to cover the 
graft. 
 The distal and proximal urethral edges are sutured together along the midline as an 
end-to-end anastomosis. 
Post-operative care: 
The average duration of post procedure hospital admission is approximately 3 days. 
Patient is maintained on oral antibiotics until the catheter is removed. Two weeks 
following surgery, the catheter is removed and voiding cysto-urethrography is obtained 
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Complications of urethroplasty: 
Early complications: 
 Wound dehiscence 
 Scrotal hematoma 
 Erectile dysfunction 
 Catheter dislodgement 
 Wound infection 
Late complications: 
 Erectile dysfunction 
 Post void dribbling 
 Diverticulum 
 Fistula 
 Chordae 
 Recurrence 
HISTORY OF NEURAXIAL ANAESTHESIA:  
Bier made history by using cocaine for intrathecal anaesthesia in 1898(25).Later on 
Neuraxial anaesthesia was  successfully performed using different local anaesthetics like 
procaine by Braun (1905), tetracaine by Sise (1935), lidocaine by Gordh (1949), 
chloroprocaine by Foldes and McNall (1952), mepivacaine by Dhunérand Sternberg 
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(1961), and bupivacaine by Emblem (1966)(22). In the 1980s spinal anaesthesia using 
ropivacaine and levobupivacaine was introduced.  
Despite the vast experience in neuraxial techniques through the past century, several 
adverse events like paraplegia after spinal anaesthesia (Woolley and Roe in 1954), 
persistent neurologic deficits, adhesive arachnoiditis with spinal chloroprocaine , and 
cauda equina syndrome with continuous spinal lidocaine anaesthesia  were reported. 
Recently, the potential for catastrophic epidural hematoma with newer potent 
anticoagulants (e.g., low-molecular-weight heparin [LMWH]) and antiplatelet agents 
(e.g., clopidogrel) has caused concern.  
ANATOMY OF SPINAL CORD: 
The spinal cord extends from brainstem proximally and terminates distally in the conus 
medullaris as the filum terminale and the cauda equina. In infants it ends at L3 vertebral 
body and in adults at the lower border of L1. Inside the bony vertebral column, spinal 
cord is surrounded by three membranes, the pia mater, the arachnoid mater, and the dura 
mater from within to outside. The cerebrospinal fluid (CSF) is present in the space 
between the pia mater and the arachnoid mater which is termed as subarachnoid or 
intrathecal space. The arachnoid mater is a non-vascular membrane which acts as the 
principal barrier to drugs crossing into and out of the CSF. The epidural space surrounds 
the duramater and extends from the foramen magnum to the sacral hiatus. It is bounded 
anteriorly by the posterior longitudinal ligaments, laterally by the pedicles and 
intervertebral foramina, and posteriorly by the ligamentum flavum. The epidural space 
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contains nerve roots, fat, areolar tissue, lymphatics, and blood vessels including the 
Batson venous plexus. Posterior to the ligamentum flavum is the lamina and spinous 
processes of vertebral bodies or the interspinous ligaments. Extending from the external 
occipital protuberance to the coccyx posterior to these structures is the supraspinous 
ligament, which joins the vertebral spines. 
SPINAL ANAESTHESIA: 
Subarachnoid block is an anaesthetic technique where anaesthesia is provided by 
injecting local anaesthetic in to the subarachnoid space. It is mainly used for lower 
abdominal surgeries, surgeries in the perineal region and lower limb surgeries. 
Technique of spinal anaesthesia: 
For giving spinal anaesthesia, patient is positioned in sitting or lateral decubitus position. 
Once skin preparation is done with antiseptic solution like betadine or chlorhexidine and 
the patient is draped. A 25G Whitacere or 25G Quinkes spinal needle is usually used in 
our institution to enter and administer drug into the subarachnoid space. Skin is infiltrated 
with 2% lignocaine prior to introducing spinal needle. Subarachnoid space is reached by 
either median or para-median approach. In median approach the palpating fingers are 
rolled from side to side and cephalad to caudad to identify the interspinous space. The 
highest point of iliac crest is used as landmark. The line joining the two iliac crests 
crosses the body of L4 or corresponds to L4-L5 intervertebral space. In para-median 
approach spinal needle is inserted 1 cm lateral and 1 cm caudad to the caudad edge of the 
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more superior vertebral spinous process and approximately 15 degrees off the sagittal 
plane. Spinal needle has to pass through skin, subcutaneous fascia, supraspinous 
ligament, interspinous ligament, ligamentum flavum and dura to reach the subarachnoid 
space. On passing through the dura there is a sensation of loss of resistence or pop 
sensation. Subarachnoid space is confirmed by free flow of C.S.F after removing stylet 
from the needle. 
Mechanism of action: 
For spinal and epidural anaesthesia, the target binding sites are located within the spinal 
cord (superficial and deep portions) and on the spinal nerve roots in the subarachnoid and 
epidural spaces. The spinal nerve roots and dorsal root ganglia are considered the most 
important sites of action. Diffusion is the primary mechanism of local anaesthetic 
distribution in the CSF from areas of high concentration toward other segments of the 
spinal cord with low drug concentration. Rostral spread after the administration of a small 
local anaesthetic dose, often evident within 10 to 20 minutes, is related to the CSF 
circulation time. Longitudinal oscillations generated by the pulsations of the arteries in 
the skull are believed to be responsible for CSF bulk flow. This likely facilitates the 
cephalad distribution of drug from the lumbar intrathecal space to the basal cisterns 
within 1hour of injection. 
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BUPIVACAINE: 
Bupivacaine was introduced in 1963 and it was used successfully for spinal anaesthesia 
by Emblem in1966(22). It is a highly protein-bound amide local anaesthetic with a slow 
onset because of its relatively high pKa. It is appropriate for procedures lasting up to 2.5 
to 3 hours. For central neuraxial blocks 0.5% preservative free bupivacaine is used. 
Mechanism of action: 
It binds to the sodium channels on the nerve fibres and inhibits the passage of sodium 
ions through ion selective sodium channels in nerve membranes and there by slows down 
the rate of depolarization of nerve action potential such that the threshold potential is not 
reached. It results in inhibition of transmission of nerve impulses. ATP- sensitive 
potassium channels in the cardiac muscle fibres are also sensitive to bupivacaine which 
explains the reason for cardio toxicity in cases which exceed the toxic doses. 
MORPHINE: 
Morphine is a hydrophilic phenanthrene derivative.  It is approximately 100 times less 
potent than fentanyl.  When compared to the lipophilic opioids, it has slow onset of action 
(15 minutes intrathecal, 30 minutes epidural), and significantly longer duration of action 
(approximately 12-24 hours). Its terminal elimination half- life is approximately 170 
minutes. It produces analgesia, sedation, euphoria etc. Analgesia is prominent when it is 
given before painful stimulus occurs. 
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NEURAXIAL OPIOIDS: (25) 
The first published report on opioids for intrathecal anaesthesia belongs to a Romanian 
surgeon, Racoviceanu-Pitesti, who presented his experience at Paris in 1901(26). Behar 
and his colleagues published the first report on the epidural use of morphine for the 
treatment of pain in The Lancet in 1979.(26) 
Mechanism of action: 
Opioids  act  as  agonists  at  opioid  receptors  that  are located in different body tissues 
including  the brain (cerebral cortex, thalamus, hypothalamus, amygdala, basal ganglia, 
brainstem, reticular activating system),  spinal  cord  and  non-neural  tissues  such  as  
the  gastrointestinal  tract. Opioid receptors are classified in to four main groups- mu, 
kappa, delta and nociceptin.  They belong to G-protein coupled inhibitory receptors. 
Different opioids have different affinities for these receptors and each class is associated 
with specific therapeutic and adverse effects. Neuraxial opioid administration provides 
analgesia by primarily binding to pre and postsynaptic mu-opioid  receptors  in  the  
substantia gelatinosa  of  the  dorsal  horn  of  the  spinal  cord. There is decreased 
conductance  through  voltage  gated  calcium  channels  and  reduced  calcium  influx  
with  subsequent decreased  neurotransmitter  release with activation  of presynaptic 
receptors on primary afferent neurons carrying nociceptive information.  It results in 
reduction of  signalling  between  primary  and  secondary  afferent neurons  in  the  
dorsal  horn. Opioid binds to the postsynaptic opioid receptors on secondary afferent 
neurons which results in hyperpolarisation and decreased propagation of action 
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potentials. Intrathecal  opioids  act  as  ligands  on  opioid  receptors  in  three  different  
areas  and  produce analgesia: 
1. Their main site of action is dorsal horn of the spinal cord. 
2. They  modulate  descending  inhibitory pain pathways when they  are  transported  
supra-spinally  by  bulk  CSF  flow  . 
3. Minor analgesic effect is due to the diffusion of small  amount  of  opioid    into  the  
epidural  space  and  subsequent  systemic  absorption which results in centrally mediated 
analgesia. 
Intrathecal opioids undergo minimal metabolism within the CSF. Lipid solubility of the 
opioid determines the onset and duration of analgesia and the degree of cephalad spread. 
Highly fat soluble opioids  like  fentanyl  and  sufentanil rapidly diffuse  into  the  spinal  
cord  and  binds to the  dorsal  horn  receptors. This produces a rapid onset of analgesia 
with less cephalad spread and low risk for delayed respiratory depression, but the 
duration of analgesia is relatively short. Morphine is water soluble, so it binds slowly to 
the dorsal horn receptors and results in a slower onset but more prolonged duration of 
analgesia. There is increased cephalad spread and subsequently an increased risk of 
delayed respiratory depression. The effects of opioids within the CSF are complex, 
because of a combination of direct spinal cord dorsal horn opioid receptor activation, 
cerebral opioid receptor activation after CSF transport, and peripheral and central 
systemic effects after vascular uptake. The effect at each of these sites depends on both 
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the dose administered and the physicochemical properties of the opioid, particularly lipid 
solubility. The spread of lipophilic opioids within the CSF is therefore more limited than 
hydrophilic opioids such as morphine, which demonstrate greater spread as a result of 
slower uptake and elimination from the CSF. 
Most common side effects of neuraxial opioids include: 
 Pruritus 
 Nausea and Vomiting 
 Ventilatory  depression 
 Sedation 
 Urinary retention 
Pruritus: 
It is one of the most common side effects with injection of opioids in to the epidural or 
subarachnoid space. It is a subjective and unpleasant sensation which provokes patient to 
scratch and is more localized to the face, neck, or upper thorax. It is usually localised to 
face supplied by the trigeminal nerve. The mechanism is likely due to the cephalad 
migration of the drug which interacts with opioid receptors in the trigeminal nucleus. 
This nucleus is rich in opioid receptors and is continuous with the substantia gelatinosa 
and Lissauer tract at C3-C4. Naloxone, an opioid antagonist is effective in relieving 
opioid induced pruritus. 
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Ventilatory Depression: 
The incidence of ventilatory depression after giving neuraxial opioids requiring treatment 
is 1percent(27). It may occur within 2hrs of neuraxial injection of opioid and may be due 
to systemic absorption. Delayed ventilatory depression occurs 6 to 12 hours after 
neuraxial injection of the drug. It is usually attributed to the cephalad migration of drug in 
the CSF and interaction of the drug with opioid receptors located in the ventral medulla. 
The risk factors for opioid induced ventilatory depression include increasing age, use of 
long-acting sedatives along with opioids, positive pressure ventilation, and pre-existing 
respiratory disease. When opioid analgesics are used during the first 12–24 h after 
intrathecal administration of morphine it results in development of early and late onset 
respiratory depression. 
Nausea and Vomiting: 
It is due to direct stimulation of the dopaminergic receptors of chemoreceptor zone (CTZ) 
in the floor of fourth ventricle. The chemoreceptor zone contains several different 
receptors that modulate its activity. It lies outside the blood–brain barrier. Most of the 
medications used to treat PONV act by either a direct or indirect antagonizing action of 
emetogenic substances on receptors in the CTZ. The known risk factors include female 
gender from puberty, non-smoking status, previous history of PONV or motion sickness, 
and genetic predisposition, use of inhalation agents, nitrous oxide, large-dose 
neostigmine, and intraoperative and postoperative opioid use, longer duration of surgery. 
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Multimodal therapy is more effective in preventing and treating PONV. They include 
serotonin antagonists like ondansetron, neurokinin, antihistamines, and benzodiazepines. 
Sedation: 
It is dose dependant. Doses up to 500 micrograms were used without significant side  
effects.(28) 
Dose of intrathecal morphine: 
There are many studies done in the past using different doses of intrathecal morphine 
ranging from 100 µgms to 4000 µgms for various surgeries. In the meta-analysis done by 
Meylan et al it was concluded that the unwanted side-effects were more in intrathecal 
morphine group who received more than 300 µgms(29). 
CLONIDINE: 
Clonidine is an imidazole which is a centrally acting selective partial alpha-2 adrenergic 
agonist and partial alpha adrenergic antagonist. It was first synthesized in 1962 as nasal 
decongestant, and marketed as antihypertensive in 1972.  It has high affinity for these 
receptors and relatively low affinity at these sites.  It decreases sympathetic nervous 
system output from the central nervous system.(30) 
Mechanism of action: 
 Clonidine acts as an alpha-agonist in the anterior hypothalamus and excites a pathway 
that inhibits excitatory cardiovascular neurons. It acts on the nucleus tractus solitarus 
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(NTS) and results in increased inhibition of sympathetic outflow from the vasomotor 
centre. In the posterior hypothalamus , it acts as an alpha-antagonist and decreases 
excitation of excitatory cardiovascular neurons, or it decrease norepinephrine release by 
acting as an alpha-presynaptic agonist and thus decreases excitation of excitatory 
cardiovascular neurons.(30) In the medulla it acts as an alpha-antagonist, inhibits 
excitatory input to the sympathetic nervous system and enhances the excitatory vagal 
cardiac reflex and the inhibitory baroreceptor reflex. All of these actions produce 
diminished sympathetic outflow from the CNS, which results in decreased arterial blood 
pressure.  
 It acts on pre-junctional and post-junctional α2 receptors in the dorsal horn of the spinal 
cord. Activation of presynaptic receptors reduces neurotransmitter release, whereas post-
junctional receptor activation results in hyperpolarization and reduction of pulse 
transmission. 
Alpha 2 consists of three subtypes. Alpha 2A, 2B, 2C. Clonidine acts on Alpha2A 
receptors and results in sedation, analgesia and sympatholysis. 
Most common side effects of clonidine are: 
 Bradycardia 
 Hypotension 
 Sedation 
 Xerostomia 
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Bradycardia: 
Tachycardia is attenuated through block of the cardio-accelerator nerves.  Bradycardia is 
due to vagal stimulation. Treatment of symptomatic bradycardia is Intravenous 
anticholinergic. 
Hypotension: 
Clonidine acts on Alpha 2 adrenergic receptors of peripheral blood vessels and results in 
vasodilation.  The decrease in systolic blood pressure is more prominent than the 
decrease in diastolic blood pressure. 
Sedation: 
Clonidine acts on locus cerulus of brain stem and results in sedation. Assessment of 
sedation is important as it may result in respiratory depression which is potentially 
disastrous. There are many scoring systems available to assess the degree of sedation like 
Richmond Agitation-Sedation Scale (RASS), Ramsay Sedation Scale (31), Pasero 
Opioid-induced Sedation Scale (POSS)(32). 
Dose of intrathecal clonidine: 
The dose of intrathecal clonidine is 75-150µgms. In the randomised control trails done by 
Tuijl et al and Ranju singh et al in caesarean section patients using 75 µgms intrathecal 
clonidine does not increase the incidence of side-effects(41) (42). Sethi B. et al used 1 
µgm/kg body weight clonidine for intrathecal injection in patients undergoing lower 
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abdominal surgeries which concluded that it increases duration of post-operative 
analgesia with increased sedation and decrease in heart rate and blood pressure which 
does not require any therapeutic intervention (37). A clinical review showed that doses 
more than 75 µgms resulted in significant hemodynamic changes (43). 
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                                PATIENT SELECTION AND METHODOLOGY 
 Settings: 
This study was carried out in the urology operating theatres and urology ward of 
Christian Medical College and Hospital, Vellore. The Department of urology performs 
about 150-200 urethroplasty surgeries per year. 
Inclusion Criteria: 
 Age between 18 to 65 years 
 ASA – 1 & 2 
 Informed consent obtained 
Exclusion Criteria: 
 Refused consent 
 Cardiac arrhythmias 
 Alpha adrenergic receptor blocker medication, Calcium channel blocker 
medication, ACE inhibitor medication and β-blockers. 
 Psychiatric illness 
 Known allergies to either: local anaesthetics, opioids and alpha-2 agents 
 Contraindications for spinal anaesthesia  
 Bodyweight>80kgs                                                                       
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METHODOLOGY: 
Type of study: 
Prospective Randomized Controlled double blinded study where the patient and principal 
investigator were blinded. 
Method of randomization: 
 Permuted block randomization of size 2, 4 or 6 of varied proportion was generated using 
SAS 9.1.3 computer software. 
Method of allocation concealment: 
Serially numbered opaque sealed envelopes with the random sequence were generated 
and one envelope was opened in the operation theatre just prior to taking up the patient 
for surgery  and the treatment allocation was provided according to the sequence 
mentioned in the envelop. 
Blinding and masking: 
Double blinding where Principal investigator and the subject were blinded. 
Primary Outcome: 
Postoperative analgesia: 
It was assessed using VAS score. It consists of a horizontal line that measures 10 cms in 
length. It is tagged at each end with a word descriptor (0-no pain, 10-worst pain ever 
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had). The patient was shown this scale and asked to mark the point that represents their 
current pain status. This is used to assess pain over 24 hours at different time intervals. Its 
greatest advantage is that it is simple to use (10). 
Secondary Outcomes: 
• Postoperative sedation: 
It is assessed using Ramsay sedation score. It is graded from 1to 6 depending the depth of 
sedation  
1.  Anxious or restless or both 
2.  Cooperative, orientated and tranquil 
3.  Responding to commands  
4.  Brisk response to stimulus  
5. Sluggish response to stimulus 
6. No response to stimulus 
• PONV (postoperative nausea and vomiting): 
It is assessed using PONV scoring system which has scores from 0 to 3 depending on the 
severity of nausea and vomiting.  
0- No nausea and not vomiting 
1- Light nausea or vomiting without previous nausea  
2- 2-Moderate nausea and/or vomiting                               
3-  3- Severe nausea and/or reoccurring vomiting      
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• Time to mobilization 
 JUSTIFICATION FOR STUDY: 
Central neuraxial opioids have the advantage of selective analgesia without sensory or 
motor blockade.   But the potentially catastrophic side effects such as delayed respiratory 
depression have prompted further research to develop non opioid analgesics with less 
side effects. Intrathecal clonidine is extensively used in various studies as an alternative 
to neuraxial opioids for control of pain. It is proven to be a potent analgesic agent with 
less opioid related side effects (6). It is given intrathecally in labour analgesia and 
orthopaedic surgery as a sole analgesic agent or mixed with opioids and local 
anaesthetics. However there is still dearth of studies using intrathecal clonidine for 
postoperative analgesia in urethroplasty surgeries 
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Detailed diagrammatic Algorithm of the study: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 VISUAL ANALOG SCORE 
 RAMSAY SEDATION SCORE 
AT 1,2,4,6,8,12 AND 24 HOURS POST-
OPERTIVELY 
ALL PATIENTS PLANNED FOR 
URETHROPLASTY OPERATION 
EXCLUDED FROM STUDY: 
 NO CONSENT 
 DOES NOT FULFILL 
INCLUSION CRITERIA 
INCLUDED IN THE STUDY: 
 CONSENT OBTAINED 
 FULFILLS INCLUSION 
CRITERIA 
COMPUTER GENERATED RANDOMISATION 
GROUP A: 
INTRATHECAL MORPHINE 
(3mcg/kg body wt.) 
GROUP B: 
INTRATHECAL CLONIDINE 
(1mcg/kg body wt.) 
STANDARD ANAESTHETIC PROTOCOL 
HEMODYNAMIC MONITORING (HR, SBP, DBP, MBP) 
AT VARIOUS INTERVALS 
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                               The study was approved by the institutional review board, and the 
participants who fulfil the inclusion criteria were enrolled for the study after taking 
informed consent. Information sheet and consent form were provided in the preoperative 
period. Consent was obtained after explanation by the primary investigator the day before 
surgery and video recording of consent process was done. No premedication was given 
on the day of surgery. In the operating room intravenous access was obtained and 
standard monitoring such as E.C.G, pulseoximeter, non-invasive blood pressure 
monitoring was done to all patients. The patients were randomly allocated into two 
groups using a computer generated block randomization. Group A received intrathecal 
morphine and Group B received intrathecal clonidine. 
Under strict aseptic conditions, using 25 gauze Whitacere needle, intrathecal space 
confirmed by free flow of C.S.F, preservative free clonidine (1microgram/kg body 
weight) with a maximum dose of 75 mcg or morphine (3 micrograms/kg body weight) 
with a maximum dose of 300mcg  is mixed with 2ml of 0.5% bupivacaine and was 
injected into the intrathecal space. After intrathecal injection of study drug general 
anaesthesia was given using I.V Fentanyl 1-2mcg/kg and I.V Propofol 1-2mg/kg and 
muscle relaxation achieved with 0.1 mg/kg Vecuronium. Patient was intubated with 
either appropriate size nasal RAE tube or oral endotracheal tube depending on whether 
buccal graft is being used for urethral reconstruction. Then patient was mechanically 
ventilated and maintained on 50% oxygen and Isoflurane. All patients received Inj. 
Paracetamol 1gm I.V prior to incision. Heart rate, systolic, diastolic blood pressure and 
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mean arterial blood pressure were recorded before and after intrathecal administration of 
drug, at the time of incision and in the recovery room. For every increase in heart rate and 
mean arterial pressure above 20% of baseline was treated with inj. Fentanyl 1mcg/kg up 
to a maximum of 5mcg/kg. Atropine, 0.3 to 0.6 mg was used to treat clinical relevant 
bradycardia is defined as <50/min or < 20% of baseline with of 
During postoperative period all patients received inj. Ondansetron 8mg I.V q6th hourly. 
During postoperative period patients were followed for 24hrs and visual analogue score, 
Ramsey sedation score, nausea and vomiting, time at which patient is mobilized post 
operatively were  recorded at 1, 2, 4, 8, 12 and 24 hours by the primary investigator. 
Rescue analgesia was given when VAS score greater than 4 which includes inj. 
Diclofenac 75mg I.V and lignocaine gargles 
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SAMPLE SIZE: 
With expected mean time of 600 (SD=120) minutes and 720(SD=180) minutes in each 
group the minimum required samples for the study is 24 in each arm (45). 
Two Means - Hypothesis testing for two means 
Standard deviation in group  I 120 
 Standard deviation in group  II 180 
 Mean difference 120 
 Effect size 0.8 
 Alpha error (%) 5 
 Power (1- beta) % 78 
 1 or 2 sided 2 
 Required sample size per group 24 
 
Statistical Methods: 
Data entry was done using Epidata software. 
Data analysis was performed using SPSS 16.0 software. 
For categorical variables, frequency tables were done and presented as bar plots. 
For continuous measurements, which was normally distributed were presented using 
mean and standard deviation. 
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Mean: 
It is also called the average. It is calculated by dividing the sum of all the data by the 
number of data. 
X=x1+x2+x3+…../n 
Standard deviation: 
This statistical tool tells us how spread out the numbers are, i.e.it shows the range across 
which our data varies from the mean value. To calculate the standard deviation we need 
to calculate the mean and variance first. 
Non-normal measurements are presented using median and interquartile range (IQR). 
Median: 
This is the middle value in a set of numbers that has been arranged in ascending order. 
Interquartile range (IQR): 
It is a measure of variability. The data is divided in to four equal parts and the values that 
divide each part are called the first, second, and third quartiles. IQR is the difference 
between the first and third quartile. 
Mean comparison between groups using Independent samples t test. (Error plot, 
histogram). 
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Pearson chi-squared test: 
This is one of the commonly used chi-squared tests. It is used to test a null hypothesis. 
This is done by two types of comparisons 1) It establishes if a frequency distribution that 
is there in a study differs from a theoretical distribution 2) It assesses if the paired 
observation of the two variables studied are independent of each other. 
Mann Whitney U test: 
For non-normal variables, nonparametric test, Mann Whitney U test is used for group 
comparison. It assesses if the independent observations made in the two study groups 
have a higher value than the other. 
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                                                        RESULTS 
The data collected have been analysed under the following categories: 
1) Pre-operative parameters 
2) Intraoperative parameters 
3) Post-operative parameters 
1) PRE-OPERATIVE PARAMETERS: 
The total numbers of patients that was recruited for the study was forty six. Twenty three 
patients were allotted to each group. Among the patients who were included in the study 
two patients from the clonidine arm were excluded from analysis, since the urologists 
after examination under anaesthesia decided not to proceed for urethroplasty surgery. 
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DESCRIPTIVE STATISTICS: 
Table1: This data describes the baseline characteristics of patient. 
 
 
 
     Variable 
     Clonidine 
       N=21 
    Mean(S.D) 
      Morphine 
        N=23 
    Mean(S.D) 
 
   P value 
  Age(in years)    39.68 12.63    39.04 9.02      0.846 
  Height(cms)    165.27 4.92   166.22 6.57      0.589 
  Weight(kg)    59.77 9.28    64.35 9.56      0.111 
  BMI    21.94 3.69    23.28 3.19      0.198 
 
Patients between the ages of 18 to 65 years were included in the study. The average age 
of the participants is the same in both groups. This is a parametric variable, so the 
statistical test used to analyse this variable is independent sample t-test. The p value is 
0.846, suggesting no significant difference in the age of patients included in both the 
arms of the study. The mean age of male population with urethral stricture was 39 years.  
Urethral   stricture is a condition which is more common in middle aged men. 
Evident from the table the mean of heights, weights, BMI were comparable in both 
groups. 
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ASA GRADE: 
In the six categories physical status classification of American society of 
Anaesthesiologists (ASA) only grade 1 and 2 patients were included in the study. 
Table 2: This table gives the number of patients in each ASA group 
 
Variable 
 
     Clonidine 
      n=21(n %) 
 
   Morphine 
    n=23(n %) 
 
     P value 
       ASA 1  
      19(90.47) 
 
   22(95.65) 
 
      0.608 
       ASA 2          2(9.52) 
 
     1(4.34) 
 
      0.608 
 
ASA grade 1= normal healthy individual. 
ASA grade 2= patients with mild systemic illness like hypertension and diabetes mellitus 
which is under control. 
44 
 
  
Graph 1: Pictorial depiction of number of ASA1 and ASA2 patients in each group 
Majority of the patients were ASA grade 1. 90.5% in the clonidine group and 95.7% in 
the morphine group belonged to ASA grade 1. Patients taking   Alpha adrenergic receptor 
blockers , Calcium channel blockers  , ACE inhibitor and ARB medications were 
excluded from the study to prevent any unwanted side-effects of clonidine like 
bradycardia and hypotension ,the ASA grade 2 patients included in the study were either 
patients with diabetes mellitus or hypothyroidism. There was no significant difference 
between the two arms with regards to the distribution of ASA 1and 2 categories. 
It has been studied in the past that certain comorbid illnesses alter pain threshold, pain 
impulse conduction and the total amount of analgesic requirement. For example, patients 
who have uncontrolled diabetes mellitus usually have associated neuropathy. Similarly 
patients with chronic kidney disease may have to be given less amount of opioids. 
Therefore patients with such comorbidities were not included in the study. (36) 
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2) INTRAOPERATIVE PARAMETERS: 
DURATION OF SURGERY: 
This was analysed to know the average surgical time in both groups. 
Table 3: This table compares the median time of duration of surgery. 
 
This parameter was analysed using median as there were skewed or outlying values in 
both groups. Therefore a mean will not represent the true data. The median duration of 
surgery was 4hrs. The P value for this data is 0.407. 
 
 
 
   25
th
 Percentile 
     (in hours) 
     75
th
Percentile 
        (in hours)
 
Median 50thPercentile 
(in hours) (IQR) 
 
Clonidine,N=21 
 
           3.15 
 
             5.50 
 
         4.0(3.15-5.50) 
 
Morphine,N=23 
 
           3.00 
 
             5.00 
 
        4.00(3.00-5.00) 
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TIME BETWEEN INJECTION OF DRUG AND PERINEAL INCISION: 
This variable is analysed to see whether the surgical stimulus was after the onset of action 
of the drug. 
Table 4: This table shows the mean time between injection of drug and perineal 
incision. 
 
 
 
 
 
P value: 0.407 
The mean duration of time between injection of clonidine and morphine to perineal 
incision are 39.67 21.89 and 40.43 22.26 minutes. 
 
 
 
 
  GROUP      N 
    Time 
 (minutes)        S. D 
  Clonidine     21     39.67       21.89 
  Morphine     23     40.43       22.26 
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NUMBER OF PATIENTS FOR WHOM BUCCAL GRAFT IS USED: 
This variable was analysed to know the distribution of patients undergoing substitution 
urethroplasty in both groups. 
Table 5: This table shows the number of patients for whom buccal graft is used. 
          GROUP 
      Total 
   
clonidine 
Morphin
e 
Type of    
urethroplasty 
Anastomotic Number of patients 
     8      9        17 
   47.1%   52.9%     100.0% 
Substitution Number of patients     13     14        27 
   48.1%   51.9%     100.0% 
Total Number of patients 
    21     23        44 
    
 
This parameter was analysed to know the distribution of patients who underwent 
substitution urethroplasty in clonidine and morphine group. Out of 44patients 27 patients 
had undergone substitution urethroplasty for whom buccal graft was used. In the 
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clonidine and morphine group 48.1% and 51.9% of patients had undergone substitution 
urethroplasty. 
 
 
Graph 2: Pictorial depiction of type of urethroplasty in both groups. 
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HEART RATE AT VARIOUS POINT OF TIME INTRAOPERATIVELY: 
This was analysed to know the response for various stimuli in the intraoperative period. 
Table 6: This table shows the mean heart rate with standard deviation at various 
time intervals. 
 
GROUP       Mean          S.D    P value 
HR Pre Induction clonidine       87.93      17.464  
morphine       84.86      17.074      0.449 
 
  
 
HR Induction clonidine       84.29      16.122      0.456 
morphine       80.64      16.658  
 
  
 
HR Intubation clonidine       82.07      11.672      0.039 
morphine       92.79      10.017  
 
  
 
HR Perineal Incision clonidine       69.29       11.652      0.216 
morphine       78.50       13.822  
 
  
 
HR Buccal incision clonidine       76.14       13.856  
morphine       84.43       14.538      0.135 
 
  
 
HR Post Extubation clonidine       89.07       17.036      0.593 
morphine       94.21       14.895  
 
  
 
 
 
The baseline heart rate in clonidine and morphine was 87.9 17.4 beats per minute and 
84.86 17.074 beats per minute. As the p value is 0.449 there is no significant difference 
in the baseline characteristics. The heart rate at intubation in clonidine and morphine 
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were 82.07±11.672 beats per minute and 92.79 ±10.017 beats per minute which shows 
significant decrease in intubation response in clonidine group. 
 
Graph 3:  Pictorial representation of changes in heart rate at various point of 
surgery 
It was noticed that there is an increase in heart rate in morphine group at the time of 
intubation while there is a significant obtundation of intubation response in the clonidine 
group as compared to morphine group as p value is 0.039. 
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SYSTOLIC, DIASTOLIC BLOOD PRESSURE, MEAN ARTERIAL PRESSURE 
AT VARIOUS POINT OF TIME INTRAOPERATIVELY: 
These variables were analysed to assess the hemodynamic stability in the two groups of 
patients. 
SYSTOLIC BLOOD PRESSURE AT VARIOUS POINT OF TIME: 
 Table 7: This table shows the mean systolic blood pressure with standard deviation 
at various time intervals 
 
 GROUP       Mean       S. D    P value 
SBP Pre Induction clonidine     130.86    16.332    0.924 
morphine     132.93    13.970  
 
  
 
SBP Induction clonidine     109.14    20.680    0.685 
morphine     112.07    20.697  
 
  
 
SBP Intubation clonidine     111.07    18.611    0.006 
morphine     131.07    27.371  
 
  
 
SBP Perineal Incision clonidine     95.36    13.253    0.055 
morphine     103.29    8.570  
 
  
 
SBP Buccal Incision clonidine     104.79    22.310    0.241 
morphine     112.64    10.142  
 
  
 
SBP Post extubation clonidine    120.79    13.227    0.384 
morphine    120.64    13.882  
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The baseline systolic blood pressure in clonidine and morphine was 87.9 17.4 and 
84.86 17.074 mm of Hg. As the p value is 0.924 there is no significant difference in the 
baseline SBP between two groups. 
 
Graph 4:  Pictorial representation of changes in SBP at various point of surgery 
It represents increase in systolic blood pressure in morphine group at the time of 
intubation than the clonidine group. Therefore clonidine group has less intubation 
response to than morphine group (p value of 0.006). 
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DIASTOLIC BLOOD PRESSURE AT VARIOUS POINT OF TIME 
INTRAOPERATIVELY: 
Table 8: This table shows the mean diastolic blood pressure with standard deviation 
at various time intervals during surgery. 
 
 
GROUP       Mean       S.D P value 
DBP Pre Induction clonidine       78.57    10.166      0.523 
morphine       82.50    9.163  
 
  
 
DBP Induction clonidine      71.79    16.163  
morphine      70.93    13.229      0.875 
 
  
 
DBP Intubation clonidine      70.93    17.416  
morphine      82.07    17.683      0.020 
 
  
 
DBP Perineal Incision clonidine      51.43    7.763      0.103 
morphine      63.14    7.167  
 
  
 
DBP Buccal Incision clonidine      58.79    11.247      0.091 
morphine      65.93    10.269  
 
  
 
DBP Post Extubation clonidine      74.86    9.813  
morphine      71.36    13.030      0.658 
 
  
 
 
The baseline DBP in clonidine and morphine was 78.5 10.1 mm of Hg and 82.5 9.16 
mm of Hg. As the p value is 0.523 there is no significant difference in the baseline 
diastolic blood pressure in two groups. 
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Graph 5:  Pictorial representation of changes in DBP at various point of surgery. 
 
From this pictorial representation it can be noticed that there is significant increase in 
diastolic blood pressure in morphine group at the time of intubation. The p value of 0.02 
signifies the blunting effect of clonidine on intubation response.  
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MEAN ARTERIAL PRESSURE AT VARIOUS POINT OF TIME 
 INTRAOPERATIVELY: 
 
Table 9: This table shows the mean of mean blood pressure with standard deviation 
at various time intervals 
 
 
 GROUP      Mean        S. D    P value 
MAP Pre Induction  Clonidine       90.36       9.881  
Morphine       92.79      12.879      0.686 
 
  
 
MAP Induction Clonidine      80.64     16.397  
Morphine      79.29     15.843      0.821 
 
  
 
MAP Intubation Clonidine      78.43     20.133      0.007 
Morphine      92.86     18.646  
 
  
 
MAP Perineal Incision Clonidine      61.57      8.689      0.001 
Morphine      71.07      7.195  
 
  
 
MAP Buccal Incision Clonidine      70.29      12.591      0.230 
Morphine      75.50      9.646  
 
  
 
MAP Post Extubation Clonidine      85.93      10.759      0.197 
Morphine      81.21      11.376  
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The baseline MAP in clonidine and morphine was 90.36 9.88 mm of Hg and 
92.79 12.87 mm of Hg. As the p value is 0.686 there is no significant difference in the 
baseline Mean blood pressure in two groups. 
Graph 6:  Pictorial representation of changes in MAP at various points of surgery 
Morphine group appears to have greater response to intubation and perineal incision. The 
change is statistically significant as p value is less than 0.05(0.007 and 0.001).This 
explains the better hemodynamic stability provided by clonidine during early 
intraoperative period. 
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TOTAL DOSE OF INTRAVENOUS FENTANYL USED INTRAOPERATIVELY: 
It gives an overview of total opioid required to maintain hemodynamic stability. 
Table 10: This table shows the total intravenous fentanyl used during the surgery 
 
 
 
 
 
 
 
                                         P value=0.673 
 
The mean amount of total fentanyl used in clonidine group was 153 59.5 micrograms 
and 146 45.98 micrograms in morphine group. As the p value for the mean is 0.673 the 
difference is not significant. 
 
 
 
 
 
 
  GROUP      N 
   Mean 
   (µgms)        S. D 
  Clonidine     21    153.10      59.571 
  Morphine     23   146.30      45.980 
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Graph 7: Pictorial representation of total I.V fentanyl used during surgery 
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TIME BETWEEN STOPPING INHALATIONAL AGENT AND EXTUBATION: 
Table 11: This table depicts the median and IQR of time between stopping 
inhalational agent and extubation. 
 
P value: 0.024 
This variable is analysed to see if whether there is any delay in extubation due to sedation 
effects of clonidine or morphine. There is no significant difference between the time 
between stopping inhalational agent and extubation. 
 
 
 
   25
th
Percentile 
     (in hours) 
 75
th
Percentile 
   (in hours)
 
Median  50thPercentile 
   (in hours)(IQR) 
 
Clonidine N=21 
 
        0.10 
 
       0.15 
 
    0.12( 0 .10-0.15) 
 
Morphine N=23 
 
        0.12                                        
 
0.25
 
    0.15(.0.12-0.25) 
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3) POSTOPERATIVE PARAMETERS: 
VISUAL ANALOGUE SCORE (VAS) AT VARIOUS POINT OF TIME: 
Table 12: This table shows the median perineal VAS scores at various time intervals 
in the post- operative period. 
 
        Clonidine 
Median value(IQR) 
       Morphine 
Median value(IQR) 
 
   P value 
  VAS at 0hrs              0               0     1.000 
  VAS at 1hrs              0               0     1.000 
  VAS at 2hrs              0               0     0.295 
  VAS at 4hrs              0               0     0.484 
  VAS at 6hrs           0(0-2)          0(0-2)     0.547 
  VAS at 8hrs           2(1-4)          2(0-2)     0.178 
  VAS at 12hrs           4(2-4)          2(2-4)     0.307 
  VAS at 24hrs           4(2-4)          3(2-4)     0.216 
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Both the groups have shown onset of pain by approximately by 6th hour in the post-
operative period.  
 
 
Graph 8:  This graph shows the trend in VAS scores from the time of extubation. 
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VAS SCORE OF ORAL CAVITY AT VARIOUS POINT OF TIME: 
Table 13: This table shows the median VAS score of buccal mucosa with standard 
deviation at various time intervals 
Visual Analogue Score 
         at (hours) 
        Clonidine 
Median value(IQR) 
        Morphine 
Median value(IQR) 
 
   P value 
                0                0               0    1.000 
                1                0               0    1.000 
                2                0               0    1.000 
                4                0          0(0-0.5)     0.704 
                6            0(0-2)          1(0-2.5)     0.648 
                8            2(1.5-4)          2.5(2-4)     0.421 
              12          2.5(2-4)          4(2-4)     0.186 
               24            3(2-4)          4(2-4.25)     0.179 
 
The trend of onset of pain can be inferred from the data, which shows that morphine 
group complained of pain at the 4
th
 postoperative hour and the clonidine group at 6th 
postoperative hour. 
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Graph 9: This graph shows the trend in buccal mucosal VAS scores from the time of 
extubation. 
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HIGHEST PERINEAL VAS SCORE: 
The highest VAS score was analysed to find out the intensity of pain in both groups over 
a period of 24hours. 
Table 14: This table shows the highest perineal VAS score in two groups at different 
time intervals. 
 
 
 
 
 
 
 
 
 
 
 
    Highest perineal 
VAS score at (hours) 
       Clonidine 
       (Median) 
    Morphine 
     (Median) 
                 0               0           0 
                1               0           0 
                2               0           0 
                4               0           0 
                6               0           0 
                8               2           2 
               12              4           2 
               24              4           3 
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Graph 10:  Pictorial depiction of highest perineal VAS score in two groups. 
 
The highest VAS score in clonidine group over a period of 24 hours was 4(median value, 
25th percentile-2.5 and 75
th
 percentile-4) and in the morphine group it was 3(median 
value, 25th percentile-2 and 75th percentile-4). The above given values are run through 
Mann-Whitney test. The resultant p value is 0.1, so this difference has no statistical 
significance. 
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HIGHEST BUCCAL VAS SCORE: 
The highest buccal mucosal VAS score was analysed to find out the analgesic effect of 
both drugs on buccal mucosa over a period of 24 hours  
Table 15: This table shows the highest buccal VAS score in two groups. 
. 
 
 
 
 
 
 
 
 
 
 
Highest Buccal VAS score 
            At (hours) 
   Clonidine 
    (Median) 
   Morphine 
   (Median) 
                   0           0          0 
                   1           0          0 
                   2                    0          0 
                   4           0          0 
                   6           0          0 
                   8           2          2 
                  12           4          2 
                  24            4          3 
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Graph 11:  Pictorial depiction of highest buccal VAS score in two groups. 
The highest VAS score in clonidine group over a period of 24 hours was 3(median value, 
25th percentile-2 and 75th percentile-4) and in the morphine group it was 4(median 
value, 25th percentile-2 and 75th percentile-4). The above given values are run through 
Mann-Whitney test. The resultant p value is 0.2, so this difference has no statistical 
significance. 
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TIME FOR RESCUE ANALGESIA:  
Table 16: This table shows the time to rescue analgesia in two groups 
 
 
 
 
       Clonidine N=21 
Number of patients / (%) 
      Morphine N=21 
Number of patients / (%) 
         At Recovery                 0                0 
         1
st 
post-op hour                 0                0 
         2
nd
 post-op hour                 0                0 
         4
th
 post-op hour              1(4.8%)                0 
        6
th
 post-op hour              2(9.5%)            1(4.3%) 
        8
th
  post-op hour              6(28.6%)            5(21.7%) 
        12
th
  post-op hour             12(57.1%)           10(43.5%) 
        24
th
  post-op hour             15(71.4%)           11(47.8%) 
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Graph 12:  Pictorial representation of time to rescue analgesia in two groups. 
It is evident that clonidine group started to get rescue analgesia by 4
th
 post-operative hour 
and morphine group by 6
th
 post-operative hour. By the end of 12
th
 post-operative hour 
more than 50% of clonidine group patients received rescue analgesia. 
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POST OPERATIVE NAUSEA AND VOMITING SCORE AT VARIOUS POINTS 
OF TIME: 
Table 17: This table shows the median PONV scores at various time intervals in the 
postoperative period. 
 
       Clonidine 
Median value(IQR) 
       Morphine 
Median value(IQR) 
   P value 
 
 PONV at 0hrs               0               0      0.322 
 PONV at 1hrs               0               0      0.179 
 PONV at 2hrs               0               0      0.025 
 PONV at 4hrs               0               0      0.591 
 PONV at 6hrs               0               0      1.000 
 PONV at 8hrs               0               0      0.172 
 PONV at 12hrs               0               0      0.339 
 PONV at 24hrs               0               0      0.339 
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Graph 13:  Pictorial representation of PONV scores at various in the post-operative 
period in clonidine group. 
 
  
Graph 14: Pictorial representation of PONV scores at various in the post-operative 
period in morphine group. 
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From the above graph it can be identified that three patients in morphine group and one 
patient in clonidine group had PONV score more than 0. However it is not statistically 
significant(p value=0.288).The statistical method used for the group comparison is 
repeated measures analysis of variance(ANOVA) and test  statistic used is Greenhouse 
Geisser test statistic. 
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POST OPERATIVE SEDATION AT VARIOUS POINTS OF TIME: 
Table 18: This table shows the median Ramsay sedation score at various time 
intervals 
Ramsay sedation score 
At (hours) 
      Clonidine 
Medianvalue (IQR) 
       Morphine 
Median value(IQR) 
   P value 
 
                0              2              2     0.506 
                1              2              2     0.258 
                2              2              2     0.063 
                4              2              2     0.134 
                6              2              2     1.000 
                8              2              2     1.000 
               12              2              2     1.000 
               24              2              2     1.000 
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Graph 15: Pictorial representation of Ramsay sedation score in clonidine group. 
 
Graph 16: Pictorial representation of Ramsay sedation score in morphine group. 
The above graph depicts that 4 patients in clonidine group and 3 patients in morphine 
group has Ramsay sedation score more than 2. However it is not statistically significant(p 
value=0.450).The statistical method used for the group comparison is repeated measures 
analysis of variance(ANOVA) and test  statistic used is Greenhouse Geisser test statistic. 
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TIME BETWEEN EXTUBATION AND ORAL INTAKE: 
Table 19: This table shows the mean with standard deviation of time between 
extubation to oral intake 
 
    GROUP         N Mean(hours)       S. D 
    
   Clonidine         21     7.0195     3.82921 
    
   Morphine 
        
        23 
     
    5.7857 
     
     2.41261 
 
   
 
P value=0.215 
 
There is no significant difference between two groups in first oral intake in the post- 
operative period. 
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TIME BETWEEN EXTUBATION AND MOBILIZATION: 
Table 20: This table shows the mean duration between extubation and mobilisation 
 
     GROUP       N= Mean(in hours)     S.D 
 
 
    Clonidine 
 
      21 
     
      17.8652 
 
    3.80504 
 
  
 
   Morphine       23       15.8813     4.13751 
 
 
   
 
 
The mean duration of mobilisation in the postoperative period in clonidine group is 
17.8 3.8hrs and 15.8 4.1hrs in morphine group. The difference is statistically 
insignificant as p value is 0.105. Table 12: It shows the median Ramsay sedation score at 
various time intervals  
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                                              DISCUSSION 
Urethroplasty, a surgical repair is attempted as corrective measure in the male urethra for 
urethral stricture after conservative and non-surgical methods does not produce the 
desired patient satisfaction.  
The perineal region is an area supplied with a profuse sensory nervous supply. Surgical 
procedures to the region may produce severe pain in the post-operative period. 
 The study was aimed at comparing two well accepted modes of postoperative analgesia, 
i.e., intrathecal morphine and intrathecal clonidine to ascertain which would produce 
better and longer post-operative analgesia (28) (43). This was also done to ascertain the 
extent of known side effects of these additives to spinal analgesia.  
Often the buccal mucosa is harvested to replace the damaged urethral mucosa. The added 
pain from the buccal donor site also adds to the postoperative pain. Our aim was to also 
determine whether the use of additives to spinal analgesia would cause a decrease pain in 
the oral cavity. 
 In this randomized control double blinded study, 46 patients were recruited, two patients 
had no surgical intervention done and hence 44 patients were only analysed. 
 The demographic profiles of the patients in both the arms of the study were comparable. 
The population predominantly consisted of middle aged men (the mean age was 40 years 
between both groups).This demographic profile was comparable to the patient population 
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selected by Gecaj-Gashi et al  study looking at the use of  intrathecal clonidine for trans 
urethral surgery (6). 
 Duration of surgery as a consideration, median value of duration of surgery in clonidine 
and morphine group was 4.0(3.15-5.50) hours and 4.00(3.00-5.00) hours. There was no 
significant difference between the two groups (p value=0.407). 
Comparison of the hemodynamic parameters between the two groups at various points of 
time during the intraoperative period was measured to look at response to surgery and 
side effects of the adjuncts with bupivacaine. Heart rate and blood pressure parameters 
had a significant less response to intubation and skin incision at the perineum with the 
clonidine group  (P value is <0.05). This may be attributed to the early onset of action of 
clonidine and its central sympatholytic effect. This is comparable to the study by Sethi B. 
et al in which  intrathecal clonidine 1micro gram per kg body weight  was given to 
patients undergoing abdominal surgery (25)(44). However, when analysing the response 
to the buccal mucosa harvest these parameters were not different between the groups. 
This lack of differential response may be explained by the delayed rostral spread of these 
adjuncts to Bupivacaine 10 mg. The hemodynamic response to extubation was 
comparable. Two patients in clonidine group have decrease in heart rate (decrease of 20 
beats per minute) at the time of perineal incision which was treated with anticholinergic 
drugs. But it is statistically insignificant (P value=0.2) Three patients in clonidine group 
have significant decrease in diastolic blood pressure (decrease of 30 mm of Hg) which 
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was treated with phenylephrine and ephedrine. It can be compared with the study done by 
Yoganarasimha et al.in patients undergoing lower abdominal surgeries.(5) 
 The use of intravenous fentanyl consumption was compared. The mean of total fentanyl 
used in clonidine group was 153+_59.5 micrograms (2.5 µgms/Kg body weight) and 
146+_45.98 micrograms (2.2 µgms/Kg body weight) in morphine group was marginally 
more with clonidine. However the difference was not significant (p value is 0.673). 
 The observations of the postoperative pain scores were divided between the patient’s 
perception of perineal site pain and buccal mucosa donor sites. Significant pain was 
defined as a VAS at or above 4 when the patient would be administered rescue analgesia 
on demand. Perineal site pain started to trend upwards by the 12
th
 hour and highest VAS 
was 4. The Clonidine group had a VAS of 4 by the 8
th
 hour and remained persistent 
during the duration of observation.  The morphine group had a highest pain score of 2, 
which remained constant for the period of observation. Contrary to expectation the VAS 
score at the buccal mucosa donor site showed an early trend to increased VAS within the 
morphine group. Morphine group had significant pain score of 4 by the 8
th
 postoperative 
hour and remained persistent, while the clonidine group did not have significant donor 
site pain for the duration of the study. Studies done in the past have shown the mean 
duration of postoperative analgesia  in clonidine group is around 8-10hours(6) (43) 
whereas morphine provides analgesia for 24 hours(3). It was found that more than 50% 
patients in clonidine group received rescue analgesia by 12th post-operative hour though 
a few number of patients received additional analgesics by 4th post-operative hour. In the 
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morphine group at 12 hours 43% of patients requested for rescue analgesia and a few 
number of patients received by 6th post-operative hour. At the end of observation period 
of the study 71.4% had rescue analgesia in the clonidine group as compared to 47.8% in 
the morphine group.  
The median time to extubation after stop of inhalation was 12 minutes in the clonidine 
arm and 15 minutes in the morphine arm, which was similar to the observation by 
Yaguchi et al by using two different doses of oral clonidine for premedication and 
assessing the extubation time after stop of volatile anaesthesia (39). Neither of these 
drugs administered intrathecally prolonged the awakening time after anaesthesia. 
 The Ramsay sedation score showed a moderately higher sedation among the patients 
who received clonidine in the first four hours as compared with the morphine however 
the difference was not statistically significant and the maximum sedation score was two. 
 Postoperative nausea and vomiting is a consequence of opioid receptor stimulation of the 
dopaminergic receptors of the chemo trigger zone. PONV of score of maximum of 2 was 
recorded in two patients during the 24 hour period. PONV score of 1 was present up to 
the first four hours in the clonidine group. Inspite of the presence of PONV there was no 
significant difference in time between extubation and first oral intake and mobilization 
between the two groups. 
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The randomized controlled trial between the use of clonidine and morphine as adjuncts to 
10mg of hyperbaric bupivacaine spinal anaesthesia in combination to spinal anaesthesia 
brought a few observations. 
Primarily, clonidine had significantly better intraoperative hemodynamic response to 
sympathetic response to painful stimulation during intubation and skin incision when 
compared to morphine. However, the postoperative period morphine had a better pain 
relief, considering that clonidine group requested for rescue analgesia as early as 4 hours 
post operatively. Despite the better perineal pain relief, the onset of pain at the buccal 
mucosal donor site was earlier with the morphine group. Morphine provided a 
moderately longer duration of pain relief compared to clonidine. This could possible 
because of the central alpha 2 agonist activity of clonidine (30). Side effects of both 
drugs, i.e., bradycardia, hypotension, sedation and PONV were minimal.  
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                                                       CONCLUSION 
1) In conclusion intrathecal clonidine is as effective as intrathecal morphine in 
providing analgesia during the first 12 hours postoperative hours among patients 
undergoing urethroplasty surgery. 
2) In patients who underwent substitution urethroplasty using buccal graft the onset 
of oral cavity pain is later in clonidine group. 
3) Clonidine provides better hemodynamic stability during laryngoscopy as 
compared to morphine (statistically significant). 
4) Intrathecal clonidine has less incidence of PONV, though statistically 
insignificant. 
5) There is no significant difference between intrathecal clonidine (1microgram per 
kg) and intrathecal morphine (3 micrograms per kg)  for postoperative sedation. 
6) There was no difference in the total amount of fentanyl used in the intraoperative 
period to supress the stress response in both group. 
7) Extubation time is similar in both the groups. 
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                                               LIMITATIONS 
1) The sample size was inadequate to assess the effect of intrathecal morphine and 
clonidine on buccal mucosal pain. A large sample size may have shown a 
statistically significant outcome for buccal mucosal VAS score between the two 
groups at various point of time. 
2) The use of patient control analgesic regime may have been a better tool in the 
post- operative analgesic management and in the assessment of total analgesic 
requirement over 24hours. 
3) A large sample size may be required to bring out a statistical significance between 
both the groups for time to rescue analgesia. 
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INFORMATION SHEET: 
STATEMENT ABOUT THE RESEARCH  
The Department of Anaesthesiology, CMC Vellore and the department of urology , CMC 
Vellore are undertaking this research project to compare two different pain relieving 
medicines morphine and  clonidine placed intrathecally in subjects undergoing 
urethroplasty surgery for urethral stricture. This is to ascertain if there is reduction in pain 
after surgery and also to see whether they have any increased side effects as drowsiness, 
nausea and vomiting and delayed mobilization after surgery. 
The subject’s participation in this research study is voluntary. Refusal to participate will 
not involve any penalty or loss of benefits to which the subject is otherwise entitled and 
there will be no compromise in the quality of care the subject receives. The subject can 
choose to withdraw from the study at any time it will not involve any penalty or loss of 
benefits to which the subject is otherwise entitled. Adequate measures will be taken to 
maintain the confidentiality of the subject’s identity and the data collected. Only those 
directly involved in the research will access the data as and when required.  
1.WHAT IS URETHROPLASTY SURGERY? 
 The urethra is an important part of the urinary tract.  It’s primary function  is to pass 
urine outside the body, this channel also has an important role in ejaculating semen from 
the reproductive tract of men. A urethral stricture is a scar in or around the urethra, which 
can block the flow of urine, and is a result of inflammation, injury or infection.Male 
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urethral stricture disease is prevalent and has a substantial impact on quality of life and 
health. Management of urethral strictures is complex and depends on the characteristics 
of the stricture. Urethral strictures are managed initially by urethral dilation and internal 
urethrotomy. For both of these procedures, the risk of recurrence is greater for men with 
longer strictures, penile urethral strictures, multiple strictures, presence of infection, or 
history of prior procedures. Long-term success rates are higher for surgical reconstruction 
with urethroplasty, with most studies showing success rates of 85–90%. 
2. HOW WILL THE SUBJECT BE ANAESTHETISED FOR THIS SURGERY? 
 The whole process of anaesthesia will be conducted by experienced and qualified 
doctors in the field of anaesthesia. The subject is made unconscious using medicines 
given through the blood and using gases which keep the subject unconscious. Medicines 
for pain relief will be injected around the spinal cord . The functioning of the heart and 
vital organs will be constantly evaluated throughout by standard monitoring devices 
attached to the subject’s body which ensures immediate detection and management of 
any untoward incident. Breathing will be supported by sophisticated 
machines(ventilators) through the entire period of anaesthesia. The subject will regain 
consciousness within few minutes of completion of the surgery. 
3.WHY IS THIS RESEARCH DONE? 
Perineum has rich nerve supply, hence patients experience pain during surgery and after 
surgery. During surgery increase in blood pressure and pulse. This rise in blood pressure 
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and pulse is harmful for the subject. In usual practice to reduce this blood pressure higher 
doses of anaesthetic medicines and other medicines to reduce blood pressure is given. 
This delays the process of regaining consciousness after the surgery. Injecting pain 
relieving medicines into the fluid around the spinal cord before starting the surgery 
prevents this increase in blood pressure and heart rate. Routinely morphine is used for 
this purpose, however there is no study done to see the efficacy of clonidine during this 
surgery which has lesser sedative and nausea and vomiting side effects  . At the end of 
the research if the beneficial effect is proved, usage of this drug can be included into the 
anaesthetic management of these surgeries in future and the information derived out of 
this research will be beneficial for medical science at large. 
4.HOW WILL THIS RESEARCH BE DONE? 
The participant will be participating in a randomised controlled research project. This is 
done when we do not know which treatment is best for treating a condition. To find out 
we need to compare different treatments. We put people into groups and give each group 
a different treatment. The results are compared to see if one is better. To ensure that the 
groups are the same, each participant is put into a group by chance (random). Around 50 
subjects need to be studied in order to make valid conclusions. The 50 subjects will be 
arbitrarily assigned to two groups based on allocation done by a computer and hence 
neither the investigating doctor nor the subject can decide which group the subject is 
going to be in. In one group medicine 1 ( morphine 3mcg/kg) and in the other group 
medicine 2 ( clonidine 1mcg) will be injected in to the fluid around the spinal cord under 
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strict aseptic conditions. After the subject is anaesthetized blood pressure and heart rate 
are measured continuously. The observations will be made at regular intervals to collect 
the necessary data for the research. The subject will be asked at multiple occasions to tell 
about the intensity of pain felt after surgery for 24hrs. 
5. WHAT ARE THE THINGS THE SUBJECT IS EXPECTED TO DO AS A PART OF 
THIS RESEARCH? 
 The subject is expected to express his intensity of pain as a score in a scale ranging from 
0 to 10 with 0 being no pain and 10 being very severe pain. This has to be done  1hr, 
2hrs, 4hrs, 6hrs, 8hrs, 12 hrs,24hrs after operation. The subject is expected to cooperate 
with  the doctor who will be assessing this pain score. 
6. HOW LONG WILL A SUBJECT NEED TO BE A PART OF THIS RESEARCH? 
The subject needs to be a part of this research only for one days; the day of the surgery 
and 24hrs after the surgery is over. There is no extra day of stay required in the hospital 
for the sake of research or any extra visit to hospital required. 
7. WHAT IS MORPHINE AND CLONIDINE?  
Morphine is opioid drug which causes pain relief  This is the most commonly used drug 
today. It is a safe drug when used within the allowed dose. Clonidine is a different group 
of drug(alpha2 agonist) which is now being widely used and is considered to be safer 
when used with in the allowed dose. 
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8. IS THERE ANY RISK FOR THE SUBJECT BECAUSE OF THE RESEARCH? 
 Both Morphine and Clonidine are drugs which are widely used and considered very safe 
when used within the recommended dose. With high doses of this drug in the blood it can 
cause respiratory depression and heart dysfunction. But in the study we are doing, the 
dose of this drug is much less than the maximum allowed dose.  In addition, our set up is 
capable of treating any such complications , if they occur. 
9. WILL THERE BE ANY DISCOMFORT FOR THE SUBJECT? 
 This spinal injection will be given after injecting local anaesthetic medicine, which 
makes skin and underlying structures numb ,hence subject has mild discomfort. 
10. WILL THE SUBJECT HAVE ANY ADVANTAGE OR BENEFIT BECAUSE OF   
PARTICIPATING IN THE STUDY? 
 There will not be any added advantage for the subject in terms of money or care  
given because of participation in this research. 
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INFORMED CONSENT: 
 Study Title: Intrathecal morphine or clonidine for postoperative analgesia in patients 
undergoing urethroplasty- a comparison. 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet  for the above study 
and have had the opportunity to ask questions.  
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected.  
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
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access. However, I understand that my identity will not be revealed in any information 
released to third parties or published.  
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) . 
(v) I agree to take part in the above study.  
(vi)I am aware of the Audio-visual recording of the Informed Consent. 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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DATA COLLECTION PROFORMA: 
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DRUG SAFETY MONITORING BOARD REPORT: 
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